Pacific Edge Limited Ordinary Shares - News & Media

Healthcare Biotechnology

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

See benefits

Articles & Videos

Pacific Edge Ltd has balanced a drop in cash costs with falls in total cash at the end of the 2024 Financial Year.

21 May 2024 10:06 (AEST)

Pacific Edge has posted steady growth in tests for its Cxbladder product, despite some corporate headwinds including a smaller sales force.

09 Apr 2024 09:38 (AEST)

Pacific Edge (ASX:PEB) has received a signed agreement from Te Whatu Ora Southern for the use of its Cxbladder genomic biomarker tests.

13 Jan 2023 11:24 (AEDT)

(20min delay)
Last 9.4¢		Change 0.008(9.30%)		Mkt cap ! n/a

Open	High	Low	Value	Volume
8.9¢	9.9¢	8.9¢	$155.2K	1.627M

No.	Vol.	Price($)
0	20000	9.3¢

Price($)	Vol.	No.
9.4¢	79695	0

Last trade - 12.59pm 26/07/2024 (20 minute delay)

PEB (NZSX) Chart